General Information
Version
6.4
Revision date
2022-11-15
Product name
Entecavir monohydrate
CAS No.
209216-23-9
REACH No
A
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H351 Suspected of causing cancer. H372 Causes damage to organs (Liver) through prolonged or repeated exposure. H372 Causes damage to organs through prolonged or repeated exposure. H351 Suspected of causing cancer.
Precautionary statements
P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Carcinogenicity (Category 2), H351 Specific target organ toxicity - repeated exposure (Category 1), Liver, H372 For the full text of the H-Statements mentioned in this Section, see Section 16.
